Skip to main content
Clinical Trials/NCT02785016
NCT02785016
Completed
N/A

Prospective, Non-Randomized, Observational Trial of the Surgical Management for Suburethral Slings in Women With Stress Urinary Incontinence

Cantonal Hospital, Frauenfeld1 site in 1 country100 target enrollmentMay 1, 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stress Urinary Incontinence
Sponsor
Cantonal Hospital, Frauenfeld
Enrollment
100
Locations
1
Primary Endpoint
Cure/improvement rate
Status
Completed
Last Updated
last month

Overview

Brief Summary

This is a prospective, non-randomized, observational, single center study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a suburethral sling operative procedure.

Detailed Description

The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires. Intraoperative procedural data will be collected. Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals. The anatomic position of the device will be characterize by introital ultrasound testing.

Registry
clinicaltrials.gov
Start Date
May 1, 2013
End Date
December 1, 2025
Last Updated
last month
Study Type
Observational
Sex
Female

Investigators

Sponsor
Cantonal Hospital, Frauenfeld
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. Volker Viereck

Prof. Dr.

Cantonal Hospital, Frauenfeld

Eligibility Criteria

Inclusion Criteria

  • Patient has objective demonstrable signs of stress urinary incontinence (SUI), including patients with intrinsic sphincter deficiency (ISD). Objective testing includes: standing stress test, urodynamics evaluation, or pad test.
  • Patient is age 18 or older.
  • Patient agrees to participate in the study, including completion of all study-related procedures and evaluations, and documents this agreement by signing the IRB/EC-approved informed consent.
  • Patient is able to fill in all questionnaires (on judgement of investigator)

Exclusion Criteria

  • Patient has an associated or suspected neurological disease.
  • Patient has an active lesion or present injury to perineum or urethra.
  • Patient has a urethral obstruction.
  • Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment.
  • The subject has current urinary tract infection.

Outcomes

Primary Outcomes

Cure/improvement rate

Time Frame: 3 months

Patients are classified as cured if the postoperative cough test (see Outcome 4 below) is negative and the degree of subjective suffering (see Outcome 2 below) improves to over 90% (VAS score of 0 or 1). Criteria for improvement are involuntary loss of only a few drops of urine during straining and an improvement of the degree of suffering to over 75% (VAS score of 2 or 3). All other patients are classified as therapeutic failures (even if they show marked improvement of one of the parameters compared with their preoperative status).

Secondary Outcomes

  • Standing Cough Stress Test(baseline, 3 and 6 months)
  • International Consultation on Incontinence Questionnaire(pre-operation, 3 and 6 months)
  • King Health Questionnaire(pre-operation, 3 and 6 months)
  • Subjective symptom assessment by visual analogue scale(3 and 6 months)
  • Post-Operative Pain Assessment(1 day)

Study Sites (1)

Loading locations...

Similar Trials